Hikma Pharmaceuticals plc is a global pharmaceutical company that develops, manufactures, and markets a wide range of generic, specialty, and branded medications. Its operations are divided into three main segments: Injectables, which supplies hospitals with generic and specialty injectable products; Branded, which offers branded generics and in-licensed patented products primarily in the MENA region; and Hikma Rx, which provides oral and respiratory generic products to the North American retail market. Hikma operates manufacturing facilities and R&D hubs across North America, Europe, and the MENA region, serving healthcare providers and patients in over 50 countries.